These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15725480)

  • 21. Bisphosphonate (YM529) delays the repair of cortical bone defect after drill-hole injury by reducing terminal differentiation of osteoblasts in the mouse femur.
    Nagashima M; Sakai A; Uchida S; Tanaka S; Tanaka M; Nakamura T
    Bone; 2005 Mar; 36(3):502-11. PubMed ID: 15777685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zoledronate synergises with imatinib mesylate to inhibit Ph primary leukaemic cell growth.
    Segawa H; Kimura S; Kuroda J; Sato K; Yokota A; Kawata E; Kamitsuji Y; Ashihara E; Yuasa T; Fujiyama Y; Ottmann OG; Maekawa T
    Br J Haematol; 2005 Aug; 130(4):558-60. PubMed ID: 16098070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-tumour effects of HL-37, a novel anthracene derivative, in-vivo and in-vitro.
    Xie SQ; Hu GQ; Zhang ZQ; Xu M; Ji BS
    J Pharm Pharmacol; 2008 Feb; 60(2):213-9. PubMed ID: 18237469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDA-II, a urinary preparation, induces growth arrest and apoptosis of human leukemia cells through inactivation of nuclear factor-kappaB in a caspase-dependent manner.
    Huang J; Yang M; Liu H; Jin J
    Food Chem Toxicol; 2009 Jan; 47(1):40-9. PubMed ID: 18761050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver metastasis models of colon cancer for evaluation of drug efficacy using NOD/Shi-scid IL2Rgammanull (NOG) mice.
    Hamada K; Monnai M; Kawai K; Nishime C; Kito C; Miyazaki N; Ohnishi Y; Nakamura M; Suemizu H
    Int J Oncol; 2008 Jan; 32(1):153-9. PubMed ID: 18097554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A newly developed bisphosphonate, YM529, is a potent apoptosis inducer of human myeloma cells.
    Takahashi R; Shimazaki C; Inaba T; Okano A; Hatsuse M; Okamoto A; Hirai H; Ashihara E; Nakagawa M
    Leuk Res; 2001 Jan; 25(1):77-83. PubMed ID: 11137564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The bisphosphonate zoledronic acid effectively targets lung cancer cells by inhibition of protein prenylation.
    Xie F; Li P; Gong J; Zhang J; Ma J
    Biochem Biophys Res Commun; 2015 Nov; 467(4):664-9. PubMed ID: 26498526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.
    Li X; Lu WL; Liang GW; Ruan GR; Hong HY; Long C; Zhang YT; Liu Y; Wang JC; Zhang X; Zhang Q
    Eur J Clin Invest; 2006 Jun; 36(6):409-18. PubMed ID: 16684125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines.
    Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S
    Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The multipotential hematopoietic growth factors, bryostatins, inhibit human leukemia cell lines in vitro.
    Gebbia V; Colucci A; Citarrella P; Di Marco P; Miserendino V; Tambone Reyes M; Teresi M; Bonaccorso R; Rausa L; Mansueto S
    J Chemother; 1989 Jul; 1(4 Suppl):1161-3. PubMed ID: 16312816
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-leukemic activities of Dictyostelium secondary metabolites: a novel aromatic metabolite, 4-methyl-5-n-pentylbenzene-1,3-diol, isolated from Dictyostelium mucoroides suppresses cell growth in human leukemia K562 and HL-60 cells.
    Kikuchi H; Oshima Y; Ichimura A; Gokan N; Hasegawa A; Hosaka K; Kubohara Y
    Life Sci; 2006 Dec; 80(2):160-5. PubMed ID: 17027864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell lines and primary adult T-cell leukaemia cells by interfering with the mevalonate pathway.
    Ishikawa C; Matsuda T; Okudaira T; Tomita M; Kawakami H; Tanaka Y; Masuda M; Ohshiro K; Ohta T; Mori N
    Br J Haematol; 2007 Feb; 136(3):424-32. PubMed ID: 17233845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MZ3 induces apoptosis in human leukemia cells.
    Fang L; He Q; Hu Y; Yang B
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):397-405. PubMed ID: 16900371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitrogen-containing bisphosphonate, YM529/ONO-5920, inhibits tumor metastasis in mouse melanoma through suppression of the Rho/ROCK pathway.
    Tanimori Y; Tsubaki M; Yamazoe Y; Satou T; Itoh T; Kidera Y; Yanae M; Yamamoto C; Kaneko J; Nishida S
    Clin Exp Metastasis; 2010 Oct; 27(7):529-38. PubMed ID: 20632074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. STI571 combined with vincristine greatly suppressed the tumor formation of multidrug-resistant K562 cells in a human-nude mice xenograft model.
    Gao L; Chen L; Fei XH; Qiu HY; Zhou H; Wang JM
    Chin Med J (Engl); 2006 Jun; 119(11):911-8. PubMed ID: 16780770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catechin, a green tea component, rapidly induces apoptosis of myeloid leukemic cells via modulation of reactive oxygen species production in vitro and inhibits tumor growth in vivo.
    Nakazato T; Ito K; Miyakawa Y; Kinjo K; Yamada T; Hozumi N; Ikeda Y; Kizaki M
    Haematologica; 2005 Mar; 90(3):317-25. PubMed ID: 15749663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a nitrogen-containing bisphosphonate, minodronate, in conjunction with a p38 mitogen activated protein kinase inhibitor or doxorubicin against malignant bone tumor cells.
    Kubo T; Shimose S; Matsuo T; Sakai A; Ochi M
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):111-6. PubMed ID: 17874104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity.
    Shin SW; Seo CY; Han H; Han JY; Jeong JS; Kwak JY; Park JI
    Clin Cancer Res; 2009 Sep; 15(17):5414-25. PubMed ID: 19690198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigation of anti-leukemia molecular mechanism of ITR-284, a carboxamide analog, in leukemia cells and its effects in WEHI-3 leukemia mice.
    Wen YF; Yang JS; Kuo SC; Hwang CS; Chung JG; Wu HC; Huang WW; Jhan JH; Lin CM; Chen HJ
    Biochem Pharmacol; 2010 Feb; 79(3):389-98. PubMed ID: 19765549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.